Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Siliq Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The historical expansion was largely driven by several key developments: a higher incidence of moderate to severe plaque psoriasis, the suboptimal results achieved with conventional systemic therapies, a surge in biologic prescriptions among dermatologists, the proliferation of clinics dedicated to dermatology, and advancements in diagnostic accuracy.
The upward trajectory observed during the forecast period is being fueled by a growing need for advanced biologics, a stronger emphasis on chronic disease control, the broadening scope of personalized immunology therapies, heightened funding for research into inflammatory conditions, and improved availability of specialty treatments for patients. Key developments shaping this period encompass a greater uptake of targeted biologic approaches, an expanding application of IL-17 pathway blockers, a heightened priority on customized psoriasis care, a wider reach through specialty pharmacy networks, and more rigorous tracking of therapeutic results.
Download A Free Sample Report For Comprehensive Market Insights:
Siliq Market Expansion Drivers: What Is Shaping Future Growth?
The escalating frequency of skin disorders is driving expansion within the siliq market moving forward. Skin disease encompasses a diverse array of conditions impacting the skin’s structure, functionality, or look, frequently stemming from infections, inflammation, genetic tendencies, autoimmune illnesses, or environmental factors. This rise in skin disease occurrence is linked to elements like shifting environmental conditions, growing pollution levels, greater sun exposure, hereditary vulnerabilities, and lifestyle choices such as inadequate nutrition and stress. Siliq proves advantageous for skin disease, especially moderate to severe plaque psoriasis, by acting on particular immune system mechanisms to decrease inflammation, enhance skin condition, and relieve signs like redness, flaking, and irritation. As an illustration, the American Cancer Society, a US nonprofit dedicated to eradicating cancer, predicted in January 2024 that 108,270 new skin cancer cases would be reported, reflecting a 3.2% uptick from the 104,930 instances recorded in 2023. Consequently, the heightened prevalence of skin disease is propelling forward momentum in the siliq market.
Siliq Market Driver: Rising Geriatric Demographics Fueling Demand For Siliq In Psoriasis Treatment
An expanding elderly demographic is expected to spur growth in the Siliq market in the years ahead. The geriatric population typically includes individuals aged 65 or older, though this age limit may differ depending on the scenario or healthcare criteria. This population segment is growing because of longer life expectancies, enhancements in medical care, and falling birth rates, resulting in a bigger share of elderly individuals worldwide. Siliq delivers advantages to the geriatric group by offering an efficient remedy for moderate to severe plaque psoriasis, aiding in symptom control and skin health improvement among older adults who might encounter fewer treatment alternatives due to age-related health issues. As a case in point, the UK Parliament’s House of Commons Library reported in July 2024 that there were 12.7 million people aged 65 and over in the UK in 2022, representing 19% of the total populace. By 2072, this figure is projected to climb to 22.1 million, or 27% of the population. Hence, the rising elderly population is fueling the expansion of the siliq market.
Siliq Market Driver: Precision Medicine’s Role In Driving Market Growth
An increasing focus on precision medicine is anticipated to accelerate growth in the siliq market. Precision medicine involves a customized approach to healthcare that customizes therapies based on a person’s genetic makeup, surroundings, and lifestyle habits. This heightened emphasis on precision medicine stems from progress in genetic studies, a deeper comprehension of individualized treatments, and the promise of superior patient results via focused therapies. Siliq supports precision medicine by offering a targeted treatment for moderate to severe plaque psoriasis through specific inhibition of the IL-17A pathway, enabling customized and more potent therapy aligned with each patient’s requirements. For example, the Personalized Medicine Coalition, a US-based group, noted that in 2023, the FDA cleared 16 new personalized therapies for rare conditions, a substantial increase from just six approvals in 2022. Therefore, the growing focus on precision medicine is set to propel the siliq market forward.
Siliq Market Segment Landscape And Growth Potential
The siliq market covered in this report is segmented –
1) By Clinical Indication: Moderate To Severe Plaque Psoriasis, Other Indications
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies
3) By End-User: Hospitals, Specialty Clinics, Home Care Settings
Siliq Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the siliq market are Valeant Pharmaceuticals International Inc.
Access The Complete Siliq Market Report:
Siliq Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the siliq market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the siliq market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model